"I believe that the development of the talent pool starts from school and, in this regard, we are already organizing several school tours for students to…
In Conversation
"We decided that we would like to create our own footprint in all of our key markets where the environment and the scale of our company…
Interview: Satish Kumar Singh – Managing Director; Shashi Shekhar Kumar – Vice President International Business, M/s Cachet Pharmaceuticals Pvt. Ltd., India

"I believe that one of the major advantage of operating in emerging markets is business viability. Whenever the economy is growing there is a lot of…
"Canada is one of those markets where if you file a product dossier completely as per current regulations, you can count on timely approvals and reasonable…
"DC is currently serving a majority of small to midcap companies and we are gradually increasing our focus on the pharmaceutical industry."
We target very different market groups, from government and university teaching hospitals with cutting edge science, to the OTC field and direct-to-consumer market
Interview: Themis Moustakas – CEO & President, Health Watch Swiss AG; General Manager, Protonmed Serbia

"We had to navigate a region containing ten languages and needed to develop a company that is quickly differentiated from the other businesses in the Serbian…
Interview: Benjamin Rousselot – Vice-President Strategy & Corporate Development, Laboratoires Diepharmex, Switzerland

"I think our major strength is our very fast decision-making process. Our management model is collaborative, and it is my duty to make sure that everyone…
Interview: Benjamin Rousselot – Vice-President Strategy & Corporate Development, Laboratoires Diepharmex, Switzerland

"I think our major strength is our very fast decision-making process. Our management model is collaborative, and it is my duty to make sure that everyone…
"Switzerland is a great environment to do business and to create and develop a business in healthcare."
"We built on our responsibility to explain to key stakeholders the benefits of considering the long-term perspective of healthcare, and in this regard, we have been…
"Market access is truly a priority in our organization, and our efforts encompass both our current portfolio as well as our upcoming oncology products."